Location History:
- 45147 Essen, DE (2001)
- Essen, DE (2001 - 2015)
- Gelsenkirchen, DE (2016)
Company Filing History:
1 out of 12 
1 out of 17 
3 out of 832,961 Years Active: 2001-2016
Title: Winfried Siffert: Innovator in Cancer Genetics
Introduction
Winfried Siffert is a notable inventor based in Essen, Germany. He has made significant contributions to the field of cancer genetics, holding a total of 5 patents. His work focuses on genetic modifications that can predict cancer risks and treatment responses.
Latest Patents
One of his latest patents involves the use of CHK2 polymorphism as a cancer marker. This invention relates to gene modifications in the human gene CHK2, which encodes checkpoint kinase 2. It aims to predict the risk and progression of cancer diseases, as well as the response to various therapeutic measures. The invention also provides individual gene variants that can be detected and validated for these purposes. Another significant patent involves the use of genetic modifications in the CHK1 gene, which codes for checkpoint kinase 1. This invention outlines an in vitro method for predicting disease risks, drug risks, and treatment success by identifying genetic modifications in the promoter region of the CHK1 gene.
Career Highlights
Winfried Siffert has worked with various institutions, including the University of Duisburg-Essen. His research has contributed to advancements in understanding cancer genetics and improving treatment strategies.
Collaborations
He has collaborated with notable individuals in his field, including Kathrin Riemann. Their joint efforts have furthered research in cancer-related genetic modifications.
Conclusion
Winfried Siffert's innovative work in cancer genetics has the potential to significantly impact the prediction and treatment of cancer diseases. His contributions through patents and collaborations highlight the importance of genetic research in modern medicine.